Uptake of genetic counseling among adult children of BRCA1/2 mutation carriers in France.
BRCA1/2
cancer
children
family relationships
gender
genetic counseling
oncology
Journal
Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
22
03
2019
revised:
05
06
2019
accepted:
01
07
2019
pubmed:
6
7
2019
medline:
17
3
2020
entrez:
6
7
2019
Statut:
ppublish
Résumé
Genetic counseling in at-risk families is known to improve cancer prevention. Our study aimed to determine the rate of uptake of genetic counseling among adult children of BRCA1/2 mutation carriers and to identify the potential psychosocial factors associated with uptake of genetic counseling. A self-reported questionnaire was mailed to 328 BRCA1/2 mutation carriers 10 years after BRCA1/2 test disclosure. Of the 233 carriers who returned the questionnaire (response rate = 71%), 135 reported having children over age 18 years and were therefore included in the analysis. Generalized estimating equations models were used to identify the factors associated with uptake of genetic counseling among adult children of mutation carriers. Data were gathered for a total of 296 children (46% male, 54% female). The vast majority were informed about the familial mutation (90.9%) and 113 (38%; 95% CI, 32%-44%) underwent genetic counseling. This percentage exceeded 80% in women over 40 years. In the multivariate model, female sex, advanced age, mutation in the father, diagnosis of cancer in the mutation-carrying parent after genetic testing, and good family relationships were all factors associated with higher uptake of genetic counseling. Adult children of BRCA1/2 mutation carriers in France do not undergo genetic counseling sufficiently often. Further studies should be conducted on the psychosocial factors that hinder the uptake of genetic counseling among adult children of BRCA1/2 mutation carriers.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1894-1900Informations de copyright
© 2019 John Wiley & Sons, Ltd.
Références
Lodder L, Frets PG, Trijsburg RW, et al. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. Eur J Hum Genet. 2001;9(7):492-500.
Black L, McClellan KA, Avard D, Knoppers BM. Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider. J Community Genet. 2013;4(2):203-214.
Bradbury AR, Dignam JJ, Ibe CN, et al. How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. J Clin Oncol. 2007;25(24):3705-3711.
Christophe V, Leroy T, Adenis C, Reich M, Vennin P. Information spreading about hereditary carriage of a BRCA1/2 mutation and ovarian cancer and rate of consultation of the concerned relatives. Bull Cancer. 2008;95(4):395-402.
Patenaude AF, Tung N, Ryan PD, et al. Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry? Psychooncology. 2013;22(9):2024-2031.
Troïan J, Apostolidis T, Touzani R, et al. Genetic information disclosure to offspring in BRCA mutation carriers. Kuala-Lumpur, Malaysia: IMPAHC: International Meeting on Psycho-social Aspects of Hereditary Cancer; 2017.
Wiseman M, Dancyger C, Michie S. Communicating genetic risk information within families: a review. Fam Cancer. 2010;9(4):691-703.
Lu KH, Wood ME, Daniels M, et al. American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol. 2014;32(8):833-840.
Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA. 2017;317(23):2402-2416.
Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2014;160(4):255-266.
den Heijer M, Seynaeve C, Vanheusden K, et al. Psychological distress in women at risk for hereditary breast cancer: the role of family communication and perceived social support. Psychooncology. 2011;20(12):1317-1323.
Julian-Reynier C, Mancini J, Mouret-Fourme E, et al. Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations. Eur J Hum Genet. 2011;19(5):500-506.
Dorval M, Nogues C, Berthet P, et al. Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec. Eur J Hum Genet. 2011;19(5):494-499.
Julian-Reynier C, Bouhnik AD, Mouret-Fourme E, et al. Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics. Genet Med. 2010;12(12):801-807.
Maheu C, Apostolidis T, Petri-Cal A, et al. French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testing. Fam Cancer. 2012;11(2):269-278.
Hesse-Biber S, An C. Within-gender differences in medical decision making among male carriers of the BRCA genetic mutation for hereditary breast cancer. Am J Mens Health. 2017;11(5):1444-1459.
Daly MB. The impact of social roles on the experience of men in BRCA1/2 families: implications for counseling. J Genet Couns. 2009;18(1):42-48.
Kissane DW, Bloch S. Family focused grief therapy: a model of family-centered care during palliative care and bereavement. Buckingham: Open University Press; 2002.
Young AL, Butow PN, Vetsch J, et al. Family communication, risk perception and cancer knowledge of young adults from BRCA1/2 families: a systematic review. J Genet Couns. 2017;26(6):1179-1196.
Pujol P, Lyonnet DS, Frebourg T, et al. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests. Breast Cancer Res Treat. 2013;141(1):135-144.
Julian-Reynier C, Resseguier N, Bouhnik AD, et al. Cigarette smoking in women after BRCA1/2 genetic test disclosure: a 5-year follow-up study of the GENEPSO PS cohort. Genet Med. 2015;17(2):117-124.
Moos RH, Moos BS. Family environment scale manual. Pao Alto, CA: Consulting Psychologists Press; 1981.
Untas A, Rascle N, Cosnefroy O, Borteyrou X, Saada Y, Koleck M. Psychometric properties of the French adaptation of the Family Relationship Index (FRI). Encéphale. 2011;37(2):110-118.
Ziegler A, Kastner C, Blettner M. The generalized estimating equations: an annotated bibliography. Biom J: J Math Methods Biosci. 1998;40(2):115-139.
Daly PA, Nolan C, Green A, et al. Predictive testing for BRCA1 and 2 mutations: a male contribution. Ann Oncol. 2003;14(4):549-553.
Evans DG, Binchy A, Shenton A, Hopwood P, Craufurd D. Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives. Clin Genet. 2009;75(2):124-132.
Narod SA, Neuhausen S, Vichodez G, et al. Rapid progression of prostate cancer in men with a BRCA2 mutation. Br J Cancer. 2008;99(2):371-374.
Engel C, Fischer C. Breast cancer risks and risk prediction models. Breast Care (Basel). 2015;10(1):7-12.
Miron-Shatz T, Hanoch Y, Katz BA, Doniger GM, Ozanne EM. Willingness to test for BRCA1/2 in high risk women: influenced by risk perception and family experience, rather than by objective or subjective numeracy? Judgm Decis Mak. 2015;10(4):386-399.
Marteau TM, Weinman J. Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med. 2006;62(6):1360-1368.
Nycum G, Avard D, Knoppers BM. Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information. Eur J Hum Genet. 2009;17(7):872-880.
Hallowell N, Ardern-Jones A, Eeles R, et al. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clin Genet. 2005;67(6):492-502.
Héritier F. Masculin/Féminin. La pensée de la différence. Paris: Odile Jacob; 1996.
Aim MA, Lelaurain S, Khatmi N, Fonte D, Bovina I, Dany L. 'Similar but different': social representations of health according to gender for French youth. J Health Psychol. June 19, 2018, 135910531878189. https://doi.org/10.1177/1359105318781894 [Epub ahead of print]